BRCA2 and breast cancer: The updated pathology-adjusted Manchester score frequently used in SA for estimating the threshold for BRCA1/2 probability (32), would be more effective in the SA population if patients with hormone receptor-positive BC (linked to the BRCA2 c.7934delG founder variant in our study cohort) is considered for testing similarly to the inclusion of triple-negative BC.